Surrozen, Inc./DE

Ownership Transactions Reported by 23 Insiders

Symbol
SRZN, SRZNW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
171 Oyster Point Blvd, Suite 400, South San Francisco, CA

Insiders trading volume in the past year

Surrozen, Inc./DE executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Column Group III Gp, Lp 10%+ Owner $9.56M +$6M +169% Apr 4, 2024
Tim Kutzkey Director, 10%+ Owner $9.56M +$6M +169% Jun 5, 2024
Benny Soffer Former Director $716K Aug 11, 2021
Kevin Livingston Former Chief Financial Officer $716K Aug 11, 2021
Life Sciences Consonance Former 10% Holder $716K Aug 11, 2021
Williams Charles O CFO and COO $142K Jun 14, 2024
Yang Li Exec. Vice President, Research $139K Jun 14, 2024
Craig C. Parker Chief Executive Officer, Director $33K Jun 14, 2024
Geertrui Vanhove Chief Medical Officer $12.3K Dec 15, 2022
Donald J. Santel Former Director $11.4K Aug 11, 2021
Christopher Haqq Former Director $11.4K Aug 11, 2021
Jennifer Jarrett Former Director $11.4K Aug 11, 2021
Yeh Wen-Chen Chief Scientific Officer $10.3K Jun 15, 2023
Anna Berkenblit Director Jun 5, 2024
Eric Bjerkholt Director Jun 5, 2024
Mitchell Blutt 10%+ Owner Dec 14, 2022
Gad Soffer Former Chief Executive Officer Aug 11, 2021
Joshua Cory House Former VP Business Development Aug 11, 2021
Mary Haak-Frendscho Director Jun 5, 2024
Shao-Lee Lin Director Jun 5, 2024
Christopher Chai Director Jun 5, 2024
David J. Woodhouse Director Jun 5, 2024
Mace Rothenberg Director Jun 5, 2024

Recent Insider Transactions by Companies or Individuals for Surrozen, Inc./DE

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.